Civil Proceedings
- Confocal endomicroscopy in patients with Crohn’s disease1/24/2022 0:00
- How alert are we in detecting microscopic colitis?1/24/2022 0:00
- How delayed diagnosis has an influence on the behaviour at diagnosis of Crohn’s disease1/24/2022 0:00
- Cutaneous manifestations in inflammatory bowel diseases: Results of a cross-sectional study1/24/2022 0:00
- Prevalence of symptomatic and latent celiac disease in inflammatory bowel diseases1/24/2022 0:00
- Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis is related to the severity of the endoscopic damage1/24/2022 0:00
- Is there any correlation between endoscopic and histological findings in IBD?1/24/2022 0:00
- Impact of magnetic resonance imaging in diagnosis and treatment strategy of patients with colonic Crohn’s disease1/24/2022 0:00
- The learning curve of confocal laser endomicroscopy in patients with inflammatory bowel disease (IBD)1/24/2022 0:00
- Inflammatory bowel disease treated with anti-TNF agents: The role of fecal calprotectin1/24/2022 0:00
- D-dimer serum levels in Crohn’s disease (CD): Correlation with disease activity and C-reactive protein1/24/2022 0:00
- Autoantibodies: A tool of diagnosis in Crohn’s disease in Egyptian population1/24/2022 0:00
- Linear ulceration in collagenous colitis1/24/2022 0:00
- Dysplasia in inflammatory bowel disease1/24/2022 0:00
- Efficacy and safety of infliximab rescue therapy after cyclosporine failure in patients with steroid-refractory ulcerative colitis: A multicenter study1/24/2022 0:00
- Long-term maintenance of clinical remission with reduced dosing frequency of adalimumab in patients with moderate to severe Crohn’s disease1/24/2022 0:00
- Efficacy and safety of beclomethasone dipropionate gastro-resistant, prolonged release tablet in mild to moderate ulcerative colitis: The Beta study1/24/2022 0:00
- Genetic mutations of thiopurine-methyltransferase (TPMT) in inflammatory bowel disease patients with normal TPMT phenotype and thiopurine-induced myelotoxicity1/24/2022 0:00
- Preclinical and toxicological assessments of the novel orally bioavailable PPAR ligand GED-0507 34-Levo for the treatment of inflammatory bowel disease1/24/2022 0:00
- Taking Swedish oat bran is superior to a usual diet in maintaining ulcerative colitis patients in remission Randomized placebo-controlled trial1/24/2022 0:00
- Efficacy of adalimumab in the treatment of ulcerative colitis1/24/2022 0:00
- Mycophenolate mofetil in inflammatory bowel diseases: A promise unfulfilled?1/24/2022 0:00
- Intravenous iron reduces platelet counts in IBD-associated thrombocytosis. A prospective, randomized, placebo-controlled trial1/24/2022 0:00
- Do we over estimate the risks of capsule endoscopy in suspected or established small bowel Crohn’s disease? A comparison with completion rates and complications observed in the setting of obscure GI bleeding1/24/2022 0:00
- Certolizumab pegol is effective at maintaining response and remission in patients with fistulizing Crohn’s disease: 3-year results from the PRECiSE 3 study1/24/2022 0:00
- Patients with Crohn’s disease treated with certolizumab pegol experienced long-term remission regardless of prior TNF-a inhibitor exposure (PRECiSE 4 study)1/24/2022 0:00
- Anaemia is more common but apparently less often treated in children than adolescents and adults with IBD1/24/2022 0:00
- Limited intra-individual variability in hypoxanthine-guanine phosphoribosyl transferase, thiopurine S-methyl transferase and xanthine oxidase activity in IBD patients during 6-thioguanine therapy1/24/2022 0:00
- Patient undergoing colectomy because of ulcerative colitis had a very high rate of surgical complications in clinical practice conditions1/24/2022 0:00
- Anti TNF therapy in elderly people in IBD: A multicentre survey1/24/2022 0:00
- Mucosal healing in ulcerative colitis patients treated with azathioprine and its influence on quality of life1/24/2022 0:00
- Atherosclerosis in patients with infammatory bowel diseases: Evaluation of several candidate factors for early detection1/24/2022 0:00
- Thiopurine-induced myelotoxicity in inflammatory bowel disease (IBD): A multicenter study1/24/2022 0:00
- Effectiveness of infliximab after adalimumab failure in Crohn’s disease1/24/2022 0:00
- Effect of anti-TNF alpha treatment on short-term post-operative complications in patients with inflammatory bowel disease: An Italian single center experience1/24/2022 0:00
- Early response to combined oral and topical mesalazine (PENTASA®) for ulcerative colitis: Post-hoc analysis of efficacy at two weeks in the PINCE trial1/24/2022 0:00
- Smokers with inflammatory bowel disease have low nicotine dependence1/24/2022 0:00
- Infliximab in steroid-refractory pediatric ulcerative colitis: Predictors of response in a prospective multicenter study1/24/2022 0:00
- Audit of prevention of opportunistic infections in immunosuppressed patients with IBD: How close are we to ECCO guidelines?1/24/2022 0:00
- Azathioprine and smoking habits are the only predictors of severe endoscopic postoperative recurrence in Crohn’s disease: Results of a prospective study1/24/2022 0:00
- Impact of medical treatments on the clinical course of inflammatory bowel diseases (IBD): Data from a French regional survey1/24/2022 0:00
- Skin complications during therapy with anti-TNFa preparations: Experience of a single centre1/24/2022 0:00
- Long-term durability of response to adalimumab treatment in Crohn’s disease1/24/2022 0:00
- Effectiveness of adalimumab in the treatment of extraintestinal manifestations of Crohn’s disease1/24/2022 0:00
- Patient response to anti-TNF dose escalation in Crohn’s disease using health claims data1/24/2022 0:00
- Mesenchymal stem cells transplantation decreases relapse development risk in patients with ulcerative colitis1/24/2022 0:00
- Recommendations from available standards on organizational aspects for the management of inflammatory bowel disease by specialist nurses1/24/2022 0:00
- Predicting outcome of infliximab treatment in Crohn’s disease1/24/2022 0:00
- Is methotrexate for inflammatory bowel diseases underused in clinical practice?1/24/2022 0:00
- Long-term results with mesalazine therapy in patients persistent with therapy at outset1/24/2022 0:00